Preliminary investigation into the use of Pleurotus tuber-regium powder as a tablet disintegrant
AbstractSome physical characteristics of the powder obtained from the mycelia of a giant edible mushroom, Pleurotus tuber-regium, has been determined. Its disintegrant ability in comparison with maize starch BP was also investigated in paracetamol tablets prepared via the wet granulation method. The results obtained showed that P. tuber-regium and maize starch BP have similar true, bulk and tapped density values. The Pleurotus powder however, showed superior flow, swelling capacity as well as water retention capacity to maize starch BP. The swelling capacity was three times that of maize starch BP Tablets prepared with P. tuber-regium powder disintegrated faster than those prepared with maize starch BP at concentrations below 10% w/w. At the disintegrant concentration of 10% w/w paracetamol tablets made from both Pleurotus powder and maize starch BP had similar disintegration times and dissolution profiles. It is believed that the ability of Pleurotus powder to swell by over three times its volume in the presence of water may explain its disintegrant ability. Pleurotus tuber-regium powder may therefore be used as an alternative to maize starch BP as a disintegrant in tableting.
Key words: Pleurotus tuber-regium, physical characteristics, paracetamol
Trop J Pharm Res, June 2002; 1(1): 29-37
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.